These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 25981142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.
    Al-Aieshy F, Malmström RE, Antovic J, Pohanka A, Rönquist-Nii Y, Berndtsson M, Al-Khalili F, Skeppholm M.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):671-9. PubMed ID: 27066956
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.
    Skeppholm M, Hjemdahl P, Antovic JP, Muhrbeck J, Eintrei J, Rönquist-Nii Y, Pohanka A, Beck O, Malmström RE.
    Thromb Res; 2014 Oct; 134(4):783-9. PubMed ID: 25172669
    [Abstract] [Full Text] [Related]

  • 5. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
    Gouin-Thibault I, Flaujac C, Delavenne X, Quenet S, Horellou MH, Laporte S, Siguret V, Lecompte T.
    Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of global laboratory methods and establishing on-therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution.
    Park SH, Seo YH, Park PW, Kim KH, Seo JY, Lee HT, Kwoun WJ, Ahn JY.
    J Clin Lab Anal; 2019 Jun; 33(5):e22869. PubMed ID: 30860622
    [Abstract] [Full Text] [Related]

  • 7. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L, Lukes J, Friedecky D, Zhanelova M, Nemcova M, Ulehlova J, Prochazkova J, Hlusi A, Palova M, Vaclavik J.
    Clin Lab; 2018 Oct 01; 64(10):1611-1621. PubMed ID: 30336535
    [Abstract] [Full Text] [Related]

  • 8. Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation.
    Miklič M, Mavri A, Vene N, Söderblom L, Božič-Mijovski M, Pohanka A, Antovic J, Malmström RE.
    Eur J Clin Pharmacol; 2019 Aug 01; 75(8):1069-1075. PubMed ID: 31139866
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles.
    Goto E, Horinaka S, Ishimitsu T, Kato T.
    Drug Metab Pharmacokinet; 2020 Feb 01; 35(1):151-159. PubMed ID: 32007354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Using a low-molecular weight heparin-calibrated anti-factor Xa assay to assess the concentration of apixaban and rivaroxaban.
    von Horn H, Rasmusson A, Söderblom L, Malmström RE, Antovic J.
    Int J Lab Hematol; 2022 Feb 01; 44(1):163-167. PubMed ID: 34523813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apixaban Levels in Octogenarian Patients with Non-valvular Atrial Fibrillation.
    Nissan R, Spectre G, Hershkovitz A, Green H, Shimony S, Cooper L, Nakav S, Shochat T, Grossman A, Fuchs S.
    Drugs Aging; 2019 Feb 01; 36(2):165-177. PubMed ID: 30460518
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. LC-MS/MS determination of apixaban (BMS-562247) and its major metabolite in human plasma: an application of polarity switching and monolithic HPLC column.
    Pursley J, Shen JX, Schuster A, Dang OT, Lehman J, Buonarati MH, Song Y, Aubry AF, Arnold ME.
    Bioanalysis; 2014 Aug 01; 6(15):2071-82. PubMed ID: 25322783
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coagulation markers in patients with venous thromboembolism treated with 10 mg apixaban twice daily.
    Ono R, Fukushima K, Yamazaki T, Yamashita D, Takahashi H, Hori Y, Nishimura K.
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Feb 01; 395(2):159-166. PubMed ID: 34851448
    [Abstract] [Full Text] [Related]

  • 20. Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method.
    Cafaro A, Stella M, Baiardi G, Barco S, Pigliasco F, Bandettini R, Nanni L, Mattioli F, Cangemi G.
    J Mass Spectrom; 2024 Sep 01; 59(9):e5081. PubMed ID: 39187037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.